Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Vitamin K Antagonist”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT05205863
What this trial is testing

Dose-Response in PD and Safety of Cofact Under VKA Anticoagulation

Who this might be right for
Healthy Volunteers
Prothya Biosolutions 69
Large-scale testing (Phase 3)Study completedNCT02281201
What this trial is testing

Study of a Prothrombin Complex Concentrate for Rapid Reversal of Coagulopathy Induced by Vitamin K Antagonists in Japanese Subjects

Who this might be right for
Acute Major BleedingReversal of Coagulopathy
CSL Behring 11
Post-approval studies (Phase 4)Study completedNCT00711308
What this trial is testing

Tinzaparin in the Treatment of the Acute Pulmonary Embolism

Who this might be right for
Acute Pulmonary Embolism
Complejo Hospitalario Xeral-Calde 102
Not applicableStudy completedNCT04099238
What this trial is testing

Burden of Ischemic Stroke and Intake of Oral Anticoagulants in Patients With Atrial Fibrillation in the UK Primary Care

Who this might be right for
Atrial Fibrillation
Bayer 3,739
Post-approval studies (Phase 4)Study completedNCT03064035
What this trial is testing

Fixed Versus Variable Dosing of 4-factor Prothrombin Complex Concentrate for Emergent Warfarin Reversal

Who this might be right for
Acute Bleeding on Long-Term Anticoagulation TherapyHemorrhageSignificant Bleeding in Patients With a Coagulopathy (Prolonged Thrombin Time)+1 more
HealthPartners Institute 79
Not applicableNot Yet RecruitingNCT07616414
What this trial is testing

Stepwise vs Standard Anticoagulation for AF Patients Undergoing CIED Implantation (STEP-AF)

Who this might be right for
Non-valvular Atrial Fibrillation (NVAF)ThromboembolismCardiac Implantable Electronic Device+2 more
Fu Wai Hospital, Beijing, China 424
Not applicableStudy completedNCT02596230
What this trial is testing

RE-COVERY DVT/PE: Global Study on Treatment Secondary Prevention of Acute Venous Thromboembolism

Who this might be right for
Venous Thromboembolism
Boehringer Ingelheim 7,797
Post-approval studies (Phase 4)Study completedNCT03799822
What this trial is testing

Oral Anticoagulation in Hemodialysis

Who this might be right for
Atrial Fibrillation
Onze Lieve Vrouw Hospital 132
Not applicableUnknownNCT03276377
What this trial is testing

VItamin K Inhibition and NeurocoGnition (VIKING)

Who this might be right for
Neurocognitive Disorders
University Hospital, Angers 100
Large-scale testing (Phase 3)UnknownNCT06143787
What this trial is testing

Effect of TXA Oral Sol 5% in Patients Treated With DOACs or VKA and Undergoing a Single or Multiple Tooth Extraction

Who this might be right for
Bleeding From TeethBleeding Prophylaxis
Hyloris Developments 280
Not applicableStudy completedNCT05804734
What this trial is testing

Vitamin K Antagonist Versus Direct Oral Anticoagulant Treatments in Hemophilia

Who this might be right for
Hemophilia AHemophilia BAnticoagulant-induced Bleeding
Groupe Maladies hémorragiques de Bretagne 54
Not applicableWithdrawnNCT02429453
What this trial is testing

FFP Versus PCC in Intracranial Hemorrhage

Who this might be right for
Intracranial Hemorrhage, TraumaticIntracranial Hemorrhage, Spontaneous
University of Utah
Large-scale testing (Phase 3)Study completedNCT00496769
What this trial is testing

A Phase III Study of Apixaban in Patients With Atrial Fibrillation

Who this might be right for
Atrial Fibrillation
Bristol-Myers Squibb 6,421
Post-approval studies (Phase 4)UnknownNCT04073316
What this trial is testing

AntiCoagulants and COGnition

Who this might be right for
Nonvalvular Atrial Fibrillation
University Hospital, Angers 48
Testing effectiveness (Phase 2)Study completedNCT00645853
What this trial is testing

Long-term Safety in Atrial Fibrillation Patients

Who this might be right for
Persistent or Permanent Nonvalvular Atrial Fibrillation
AstraZeneca 523
Not applicableNot Yet RecruitingNCT07330869
What this trial is testing

Warfarin Effects on Male Fertility After Cardiac Surgery

Who this might be right for
Male InfertilityHeart Valve Disease
Città di Lecce Hospital, GVM Care & Research 90
Large-scale testing (Phase 3)Study completedNCT02933697
What this trial is testing

Compare Apixaban and Vitamin-K Antagonists in Patients With Atrial Fibrillation (AF) and End-Stage Kidney Disease (ESKD)

Who this might be right for
Atrial FibrillationEnd-stage Kidney Disease
Atrial Fibrillation Network 108
Not applicableStudy completedNCT05907772
What this trial is testing

Incorporation of Protein Induced by Vitamin K Absence or Antagonist-II Into Transplant Criteria Expands Beneficiaries of Liver Transplantation for Hepatocellular Carcinoma

Who this might be right for
Cancer of Liver
Zhejiang University 522
Not applicableNot Yet RecruitingNCT07570511
What this trial is testing

Point of Care Testing INR in Antiphospholipid Syndrome

Who this might be right for
Antiphospholipid SyndromeVitamine K Antagonist (VKA) Treatment
Central Hospital, Nancy, France 150
Testing effectiveness (Phase 2)Study completedNCT02998905
What this trial is testing

NOACs for Stroke Prevention in Patients With Atrial Fibrillation and Previous ICH

Who this might be right for
Atrial FibrillationIntracerebral Hemorrhage
Population Health Research Institute 30
Next Page